PROCEPT BioRobotics

PROCEPT BioRobotics is a company focused on redefining BPH treatment. Its pioneering solution, Aquablation therapy, is described as the only ultrasound-guided, robotic-assisted, waterjet treatment for BPH across prostates of all shapes and sizes. The company offers the HYDROS Robotic System, a next-generation, AI-powered robotic platform for Aquablation therapy, featuring AI-powered treatment planning with FirstAssist AI, advanced image guidance, robotic resection, and a streamlined workflow. The company states its mission is to revolutionize BPH treatment globally in partnership with urologists by delivering best-in-class robotic solutions.

PROCEPT BioRobotics was founded on the belief that there is a better way to treat BPH. Its pioneering solution, Aquablation therapy, emerged from the intersection of medical expertise, technological innovation, and deep empathy for every patient. The company is revolutionizing the treatment of BPH to improve the lives of men around the world.

Redefining choices in men's health through advanced robotic treatments for BPH.

• Aquablation therapy

  The only ultrasound-guided, robotic-assisted, waterjet treatment for BPH across prostates of all shapes and sizes.

• HYDROS Robotic System

  The next-generation, AI-powered platform for Aquablation therapy, featuring AI-powered treatment planning with FirstAssist AI, advanced image guidance, robotic resection, and a streamlined workflow.

• 2026.11.04

  Reported2026.11.04

  PROCEPT BioRobotics reports third-quarter 2026 results[5]PROCEPT BioRobotics公布2026年第三季度业绩manilatimes.net

  PROCEPT BioRobotics reported unaudited financial results for the quarter ended September 30, 2026, including revenue of $98.3 million and a net loss of $26.5 million.

• Unconfirmed

  Reported2026.09.21

  Lead plaintiff deadline of September 22, 2026 in securities fraud class action lawsuit involving PROCEPT BioRobotics[6]涉及PROCEPT BioRobotics的证券欺诈集体诉讼首席原告截止期限为2026年9月22日news.google.com

  Investors have been alerted to a September 22, 2026 lead plaintiff deadline in a securities fraud class action lawsuit involving PROCEPT BioRobotics Corporation.

Read more

1. 1Robotic Treatments for Men's Health | PROCEPT BioRoboticsprocept-biorobotics.com
2. 2Innovators in BPH Treatment | About PROCEPT BioRoboticsprocept-biorobotics.com
3. 3HYDROS Robotic System for BPH | PROCEPT BioRobotics®procept-biorobotics.com
4. 4PROCEPT BioRoboticswikidata.org
5. 5PROCEPT BioRobotics公布2026年第三季度业绩manilatimes.net
6. 6涉及PROCEPT BioRobotics的证券欺诈集体诉讼首席原告截止期限为2026年9月22日news.google.com
7. 7PRCT Investor Announcement: PROCEPT BioRobotics Sued on behalf of Investors to Recover Losses after Artificially Inflated Revenue Leads to 18% Stock Dropprnewswire.com
8. 8PROCEPT BioRobotics (NASDAQ:PRCT) Announces Earnings Results, Misses Estimates By $0.07 EPSdailypolitical.com
9. 9PROCEPT BioRobotics (NASDAQ:PRCT) Announces Quarterly Earnings Resultstickerreport.com